Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02936115 · ClinicalTrials.gov registry record · Phase 4
TruSkin®: Study for the Treatment of Chronic Diabetic Foot Ulcers
A Phase 4 study, sponsored by Osiris Therapeutics.
- Terminated
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT02936115 is a Phase 4 study that was terminated before completion, run by Osiris Therapeutics. The registered enrollment target is 14 participants.
The verdict
NCT02936115, a Phase 4 study, was terminated before completion, sponsored by Osiris Therapeutics.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the clinical outcomes of TruSkin® and an Active Comparator in patients with chronic diabetic foot ulcers.
Interventions
- OTHER TruSkin®
- OTHER Wound Cover
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02936115
The ClinicalTrials.gov registry entry for NCT02936115 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Osiris Therapeutics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TruSkin® is the first listed.
NCT02936115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02936115 about?
NCT02936115 is a clinical study titled "TruSkin®: Study for the Treatment of Chronic Diabetic Foot Ulcers". The purpose of this study is to compare the clinical outcomes of TruSkin® and an Active Comparator in patients with chronic diabetic foot ulcers.
What is the current status of trial NCT02936115?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2016-07. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02936115?
The interventions under investigation include: TruSkin® (OTHER), Wound Cover (OTHER).
Who is sponsoring clinical trial NCT02936115?
This trial is sponsored by Osiris Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.